James Plante
vc
About
James "Jim" Plante is a technology and biotech entrepreneur-investor who founded Thynk Capital, a privately owned early-stage investment group focused on therapeutics, healthcare, and technology. He also describes himself as CEO, Founder, and Chairman of Klotho Therapeutics and as the founder and former CEO of Pathway Genomics; his Thynk biography also cites prior leadership at SmartDrive Systems and E-Band Communications. His stated motivation in longevity and kidney-disease investing comes from a family history of polycystic kidney disease.
Areas of interest
longevitybiotechtherapeuticshealthcaretechnologykidney diseaseagingAlzheimer's diseasecancerdiabetesfrailty